We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 81 results
  1. From the periphery to the brain: Wiring the olfactory system

    The olfactory system represents a perfect model to study the interactions between the central and peripheral nervous systems in order to establish a...

    Albert Blanchart, Laura López-Mascaraque in Translational Neuroscience
    Article 28 December 2011
  2. A peculiar constellation of tau pathology defines a subset of dementia in the elderly

    Sporadic tauopathies are characterized by differential cellular and topographical predominance of phospho-tau immunoreactivity and biochemical...

    Gabor G. Kovacs, Kinga Molnár, ... Herbert Budka in Acta Neuropathologica
    Article 25 March 2011
  3. Neuropathological background of phenotypical variability in frontotemporal dementia

    Frontotemporal lobar degeneration (FTLD) is the umbrella term encompassing a heterogeneous group of pathological disorders. With recent discoveries,...

    Keith A. Josephs, John R. Hodges, ... Dennis W. Dickson in Acta Neuropathologica
    Article Open access 26 May 2011
  4. Poster Session I

    Article 27 November 2013
  5. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity

    Tau is the pathological protein in several neurodegenerative disorders classified as frontotemporal lobar degeneration (FTLD), including corticobasal...

    Yong-Juan Fu, Yasushi Nishihira, ... Hitoshi Takahashi in Acta Neuropathologica
    Article 07 February 2010
  6. Abnormal tau phosphorylation in primary progressive multiple sclerosis

    Although neurodegeneration is the pathological substrate of progression in multiple sclerosis (MS), the underlying mechanisms remain unresolved....

    Jane Marian Anderson, Rickie Patani, ... Siddharthan Chandran in Acta Neuropathologica
    Article 21 March 2010
  7. Brain biopsy in dementia: clinical indications and diagnostic approach

    Brain biopsy may be performed to make a definitive diagnosis in patients with rapidly progressive dementia. To assess the value of this procedure, we...

    Jonathan M. Schott, Lilla Reiniger, ... Tamas Revesz in Acta Neuropathologica
    Article 18 July 2010
  8. Biological fluid biomarkers in neurodegenerative parkinsonism

    Patients with parkinsonian symptoms can present either to primary care physicians or to neurologists. In both contexts, differential diagnosis is...

    Michael Eller, David R. Williams in Nature Reviews Neurology
    Article 01 September 2009
  9. Synaptic organization of the olfactory bulb based on chemical coding of neurons

    Olfaction is one of the chemical senses in both vertebrate and invertebrate animals essential for a variety of social behaviors. Recent molecular...

    Article 01 December 2008
  10. Molekulare Neuropathologie der Nicht-Alzheimer-Demenzen

    The increasing life expectancy will cause an increasing share for neurodegenerative and dementing illnesses in the total cost for health care. New...

    M. Neumann, H.A. Kretzschmar in Der Pathologe
    Article 06 September 2008
  11. Argyrophilic thorny astrocyte clusters in association with Alzheimer’s disease pathology in possible primary progressive aphasia

    Although most cases of primary progressive aphasia (PPA) have one of the varieties of frontotemporal lobar degeneration (FTLD) as their pathological...

    David G. Munoz, John Woulfe, Andrew Kertesz in Acta Neuropathologica
    Article Open access 19 July 2007
  12. Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases

    In eight cases of progressive supranuclear palsy (PSP), neurofibrillary tangles (NFT) were numerous in the substantia nigra (SN), red nucleus (RN),...

    R. A. Armstrong, P. L. Lantos, N. J. Cairns in Journal of Neural Transmission
    Article 07 August 2007
  13. MAPT S305I mutation: implications for argyrophilic grain disease

    Frontotemporal lobar degeneration (FTLD) with mutations in the tau gene (MAPT) causes familial frontotemporal dementia with tau pathology. Many of...

    Gabor G. Kovacs, Alan Pittman, ... Rohan de Silva in Acta Neuropathologica
    Article 08 December 2007
  14. Hippocampal sclerosis dementia: a reappraisal

    Hippocampal sclerosis (HpScl) is characterized by neuronal loss and gliosis in CA1 and subiculum of the hippocampus, and may be one contributing...

    Alphonse Probst, Kirsten I. Taylor, Markus Tolnay in Acta Neuropathologica
    Article 17 July 2007
  15. Phosphorylation and cleavage of tau in non-AD tauopathies

    The tau protein, well known as the primary component of neurofibrillary tangles, also comprises the Pick bodies found in Pick’s disease (PiD) and the...

    Angela L. Guillozet-Bongaarts, Kelly E. Glajch, ... Lester I. Binder in Acta Neuropathologica
    Article 15 March 2007
  16. The novel Tau mutation G335S: clinical, neuropathological and molecular characterization

    Mutations in Tau cause the inherited neurodegenerative disease, frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). Known...

    Salvatore Spina, Jill R. Murrell, ... Catherine Keohane in Acta Neuropathologica
    Article 22 December 2006
  17. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer’s disease and tauopathies to granulovacuolar degeneration bodies

    Protein misfolding is a distinguishing feature of a number of neurodegenerative diseases. Accumulation of misfolded protein often results in cellular...

    Sarita Lagalwar, Robert W. Berry, Lester I. Binder in Acta Neuropathologica
    Article 07 November 2006
  18. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases

    Immunohistochemical detection of protein components of pathological inclusions is widely used for neuropathological diagnosis of neurodegenerative...

    Gábor G. Kovács, Ellen Gelpi, ... Judit Ovádi in Acta Neuropathologica
    Article 23 November 2006
  19. Pathologic changes of progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy

    Progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy (MSA) are manifested as atypical parkinsonism....

    Hideo Mori in Journal of Neurology
    Article 01 August 2006
Did you find what you were looking for? Share feedback.